On Demand WebinarNeuer Ansatz in der Implantattherapie von Patienten unter Antikoagulant-Medikation (DOAC)
Stefan Grümer M.Sc.
LEIPZIG, Germany: The global dental market has been described as “impressively resilient” and “a necessity” in the latest round of conference calls hosted by major dental companies. Dentists struggled in 2020 and so did the companies that keep their clinics stocked, but sales in the fifth financial quarter affected by the SARS-CoV-2 outbreak make it clear that practices around the world are open and offering most dental procedures.
May 20, 2021 | Education
Ein implantologischer Eingriff birgt für Patientinnen und Patienten, die unter einer Blutgerinnungsstörung leiden bzw. blutgerinnungshemmende Medikamente einnehmen, besondere Risiken. In einem kommenden Webinar wird Dr. Stefan Grümer, Spezialist für Implantologie und Laserzahnheilkunde sowie Leiter der klinischen Ausbildung im Masterstudiengang Laser in der Zahnmedizin an der RWTH Aachen, einen neuen Behandlungsansatz vorstellen. Die neue Methode soll eine Erweiterung des Therapiespektrums für jene Patientinnen und Patienten bieten, für die eine konventionelle Implantation nicht geeignet ist.
January 15, 2021 | Business
IRVINE, Calif., U.S.: The dental laser innovator BIOLASE has announced an agreement with Dental Care Alliance (DCA), one of the largest dental support organizations in the U.S. with more than 330 affiliated practices in 20 states. With this joint effort, they aim to expand laser adoption and hands-on training programs in targeted geographical areas.
FOOTHILL RANCH, Calif., U.S.: Medical device company BIOLASE expects that its U.S. sales revenue for the third quarter of 2020 will be in line with that of the corresponding pre-COVID-19 period last year. The company’s sales fell sharply in the first half of this year, but its preliminary earnings announcement will bring a degree of optimism as a host of major dental companies prepare to release their third quarter earnings reports in the coming weeks.
July 31, 2020 | Advertorial
IRVINE, Calif., U.S.: BIOLASE, a global leader in dental lasers, has reported the results of a clinical trial conducted at the McGuire Institute. Designed to meet the stringent American Academy of Periodontology best-evidence consensus standards, this first-of-its-kind study compared the BIOLASE REPAIR Perio protocol with conventional minimally invasive surgical treatment for moderate to severe generalized periodontitis.
May 22, 2020 | Education
The BIOLASE Academy went live at the end of March. Hosted by leading dental laser manufacturer, BIOLASE, this new online educational platform is dedicated to providing accessible and certified continuing education opportunities to dental professionals working with laser treatments. With periodontal disease possibly the most widespread chronic disease in the world, an upcoming webinar on the platform will present a new therapeutic approach to using lasers in order to improve periodontal treatment outcomes.
May 18, 2020 | Business
NEW YORK, U.S.: Dentistry faces an earnest struggle to adapt to what some have called the new reality. A series of investor updates from major dental companies shows us that digital tools are now more important than ever for education and in customer service environments. Some dental companies have taken extraordinary measures to sure up manufacturing and supply, and significant adverse financial impacts have been shouldered.
May 12, 2020 | Advertorial
IRVINE, Calif., U.S.: As dental offices are beginning to reopen, the American Dental Association has issued guidance recommending the reduction of aerosol production as much as possible in order to help prevent the transmission of SARS-CoV-2. A key factor in aerosol production is water usage. BIOLASE, a global leader in dental lasers, is pleased to announce that dentists can rely on Waterlase dental lasers during this critical time because they use 80% less water than traditional dental handpieces do.
IRVINE, Calif., U.S.: Limited shipping activities have restarted at the California facility of medical device company BIOLASE, as its technology and consumables are deemed essential supplies for medical professionals.